Zevra Therapeutics Inc.

About Zevra Therapeutics Inc.

Zevra Therapeutics is a rare disease therapeutics company focused on developing and delivering therapies that address significant unmet needs of patients. Comprised of expert scientists, patient advocates, and business strategists, they aim to overcome traditional drug development challenges by prioritizing patient needs and following data-driven approaches.

Products & Services

MIPLYFFA(r):A commercial product offered by Zevra Therapeutics.

Specialties

Rare Disease Therapeutics Drug Development for Unmet Needs Clinical Trials Patient Advocacy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 60000000 MR: - FA: approximately $60.0 million FAN: 60000000	D: 2024-08-08 FD: 2024-08-08	4 investors
2	RT: Debt T: - FT: Debt	A: 100000000 MR: - FA: up to $100M FAN: 100000000	D: 2024-04-10 FD: 2024-04-10	2 investors

Underwritten Public Offering Latest

2024-08-08

$60.0M

4 investors (Pro only)

Debt 2024-04-10

$100.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Neil F. McFarlane

President and Chief Executive Officer

R

R. LaDuane Clifton

Chief Financial Officer & Treasurer

J

Joshua Schafer

Chief Commercial Officer

A

Adrian Quartel, M.D., FFPM

Chief Medical Officer

R

Rahsaan W. Thompson

Chief Legal Officer, Secretary and Compliance Officer

A

Alison Peters

Chief People Officer

View 19 more team members with Pro

Unlock Full Team Directory

Recent News